Entering text into the input field will update the search result below

Editas Medicine, Inc. (EDIT) CEO Jim Mullen on Q1 2021 Results - Earnings Call Transcript

May 05, 2021 1:40 PM ETEditas Medicine, Inc. (EDIT) Stock
SA Transcripts profile picture
SA Transcripts

Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2021 Earnings Conference Call May 5, 2021 8:00 AM ET

Company Participants

Ron Moldaver - Investor Relations

Jim Mullen - Chief Executive Officer

Lisa Michaels - Chief Medical Officer

Michelle Robertson - Chief Financial Officer

Conference Call Participants

Joon Lee - Truist Securities

Cory Kasimov - J.P. Morgan Securities

Phil Nadeau - Cowen & Company

Gena Wang - Barclays Capital

Yanan Zhu - Wells Fargo Securities

Steven Seedhouse - Raymond James

Madhu Kumar - Goldman Sachs & Co.

Luca Issi - RBC Capital Markets

Costa Sean - Morgan Stanley & Co.

Jay Olson - Oppenheimer & Co.


Good day and thank you for standing by. Welcome to the Q1 2021 Editas Medicine Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]

I would now like to hand the conference over to your first speaker today, Ron Moldaver, Investor Relations. Please go ahead.

Ron Moldaver

Thank you, Julian. Good morning, everyone, and welcome to our first quarter 2021 conference call. Earlier this morning, we issued a press release providing our financial results and corporate updates for the first quarter of 2021. A replay of today's call will be available on the Investors section of our website approximately 2 hours after its completion. After our prepared remarks, we will open the call for Q&A.

As a reminder, various remarks that we make during this call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our most recent annual report on Form 10-K, which is on file with the SEC.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About EDIT

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on EDIT

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.